As HSP90 was suggested to be a specific surface marker of human breast CSCs, an anti-HSP90 monoclonal antibody 4C5 was produced, which inhibited both the cancer stemness-related activity of human breast cancer cells in vitro and the primary growth of mammosphere-derived tumors in immunodeficient mice [106]. Here, HSP90AA1 is linked to breast carcinoma.